Before we get too far into 2021, I thought I’d write a thread recapping some of the research that came out of my lab in 2020. Most of this work was led by my talented team of graduate students, Kerrianne Morrison, @kmdebrabander, and @DesiRJones.

Back in January, a news story was published about Kerrianne’s study showing improved social interaction outcomes for autistic adults when paired with another autistic partner. https://t.co/3hct0yZ3Ly
A detailed thread about the study and a link to the paper can be found here (feel free to DM me your email address if you’d like a copy of the full paper for this study or any of our studies): https://t.co/Sc7B2ob6h0
Another paper published early in 2020 (it appeared a few months earlier online) showed that traditional standalone tasks of social cognition are less predictive of functional and social skills among autistic adults than commonly assumed in autism research. https://t.co/96HTjX75Rk
Next, @kmdebrabander led and published an innovative study about how well autistic and non-autistic adults can predict their own cognitive and social cognitive performance. https://t.co/GbDkZzNe67
Meanwhile, @DesiRJones was making huge strides highlighting how the woeful underrepresentation of Black scientists and Black autistic people within autism research affects cultural assumptions and clinical practice. https://t.co/0V1H0eS9Mt
Desi also hosted this powerful round table about the experiences of Black, Indigenous, and Latinx autistic adults. https://t.co/KNOjygLZcd
She then participated in this thoughtful podcast produced by @Spectrum about being Black in autism research. https://t.co/SnoArruJ3a
Our lab then published a paper supporting the “double empathy theory” by @milton_damian showing that traditional measures and notions of social skill, social motivation, and social cognition have almost no relation to the real-world social interaction outcomes of autistic adults. https://t.co/2ZyK3qIkr8
My lab isn’t an island, though! We continue to pursue collaborations with wonderful colleagues around the country (and now internationally as well! @cjcrompton @SueReviews among others). For instance...
I was thrilled to be part of this incisive and righteous paper led by @KristenBott about avoiding ableist language when taking about and researching autism. https://t.co/sC3MxSVdql
I’m also so lucky to continue to work with @ClareHarropPhD and colleagues examining sex differences in social and non-social attention in autistic children. We have a series of papers on this topic. Here’s the latest that came@out this year: https://t.co/BNluinj2gx
We have several other papers coming out soon, including a really important (IMO) study led by @DesiRJones testing how well an autism acceptance “intervention” for non-autistic adults reduces explicit and implicit biases about autism. Stay tuned!

More from Health

No-regret #hydrogen:
Charting early steps for H₂ infrastructure in Europe.

👉Summary of conclusions of a new study by @AgoraEW @AFRY_global @Ma_Deutsch @gnievchenko (1/17)
https://t.co/YA50FA57Em


The idea behind this study is that future hydrogen demand is highly uncertain and we don’t want to spend tens of billions of euros to repurpose a network which won’t be needed. For instance, hydrogen in ground transport is a hotly debated topic
https://t.co/RlnqDYVzpr (2/17)

Similar things can be said about heat. 40% of today’s industrial natural gas use in the EU goes to heat below 100°C and therefore is within range of electric heat pumps – whose performance factors far exceed 100%. (3/17)


Even for higher temperatures, a range of power-to-heat (PtH) options can be more energy-efficient than hydrogen and should be considered first. Available PtH technologies can cover all temperature levels needed in industrial production (e.g. electric arc furnace: 3500°C). (4/17)


In our view, hydrogen use for feedstock and chemical reactions is the only inescapable source of industrial hydrogen demand in Europe that does not lend itself to electrification. Examples include ammonia, steel, and petrochemical industries. (5/17)
On 18.12.2020, computer engineer @FitTuber shared @YouTube video titled "10 Safe & Useful Ayurvedic Tablets to Replace Allopathic Pills (Instant Relief)". The drugs he promoted were by @baidyanathgroup, not sure if it was paid promotion. I bought them:
https://t.co/w6Sh2pMvJf


10 drugs, details, batch numbers R given in pic👇. All by @baidyanathgroup exept 1 by https://t.co/tg46sBhJr2
We did GCMSMS, ICP-OES and FTIR analyses on these samples. Here are my 10 safer modern medicine alternatives 2 @FitTuber's untested, potentially harmful #Ayurvedic drugs


Kanthsudharak Vati by Unjha Pharma
@FitTuber: 4 sorethroat, cold, cough
Analysis: Lead 0.54 mg/kg, Cadmium 0.4 mg/kg, Thallium 0.71 mg/kg and industrial phenols.
Low values, but not ideal.

Safe alternative: Levocetrizine & non-sedative cough syrup Levodropropizine


Baidyanath Rajbati
@Fittuber: for bloating, gas
Analysis:
Mercury 1.2 mg/kg
Arsenic 2.25 mg/kg
Male anabolic hormone - hydroxy testosterone+
Curcumin
Talc powder

Safer alternative: activated charcoal+simethicone (non-absorbed, no side effects) or short course esomeprazole.


Baidyanath Bilwadi Choorna
@Fittuber - 4 diarrhoea
Analysis
Thallium 3.68 mg/kg
[fun fact: 10-15 mg/kg is lethal dose for humans. Death can occur at lower dosages] https://t.co/9ozOKROhCK
Fenretinide - synthetic anti-cancer drug
Liver toxic chromium phosph.

Safer: Racecadotril

You May Also Like